X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (394) 394
humans (378) 378
continuous intravenous epoprostenol (315) 315
hypertension, pulmonary - drug therapy (213) 213
pulmonary hypertension (198) 198
cardiac & cardiovascular systems (144) 144
female (136) 136
therapy (136) 136
respiratory system (131) 131
prostacyclin (130) 130
male (125) 125
pulmonary arterial hypertension (121) 121
hypertension, pulmonary - physiopathology (117) 117
survival (117) 117
abridged index medicus (110) 110
antihypertensive agents - therapeutic use (105) 105
double-blind (101) 101
middle aged (99) 99
placebo-controlled trial (97) 97
adult (93) 93
prostacyclin analog (93) 93
inhaled iloprost (88) 88
epoprostenol - therapeutic use (84) 84
treatment outcome (81) 81
calcium-channel blockers (74) 74
pharmacology & pharmacy (74) 74
continuous intravenous prostacyclin (71) 71
epoprostenol (71) 71
hypertension, pulmonary - diagnosis (71) 71
disease (69) 69
arterial-hypertension (68) 68
inhaled nitric-oxide (68) 68
drug therapy (67) 67
hypertension, pulmonary - etiology (67) 67
care and treatment (66) 66
hypertension, pulmonary - therapy (65) 65
bosentan (63) 63
controlled-trial (62) 62
epoprostenol - analogs & derivatives (62) 62
vasodilator agents - therapeutic use (61) 61
medicine, general & internal (59) 59
endothelin-receptor antagonist (58) 58
hypertension (58) 58
aged (56) 56
long-term treatment (56) 56
treprostinil (54) 54
endothelin receptor antagonists (52) 52
epoprostenol - administration & dosage (51) 51
antihypertensive agents - administration & dosage (48) 48
iloprost (47) 47
drug therapy, combination (46) 46
scleroderma (42) 42
critical care medicine (41) 41
mortality (41) 41
animals (39) 39
randomized controlled-trial (39) 39
phosphodiesterase inhibitors - therapeutic use (37) 37
hemodynamics (36) 36
hypertension, pulmonary - mortality (36) 36
prognosis (36) 36
infusion (35) 35
pulmonary arteries (35) 35
research (35) 35
sildenafil (34) 34
familial primary pulmonary hypertension (33) 33
calcium channel blockers - therapeutic use (31) 31
combination therapy (31) 31
diagnosis (31) 31
antihypertensive agents - adverse effects (30) 30
endothelin (30) 30
epoprostenol - adverse effects (30) 30
lung transplantation (30) 30
prostaglandins - therapeutic use (30) 30
sulfonamides - therapeutic use (30) 30
oral sildenafil (29) 29
randomized controlled trials as topic (29) 29
risk factors (29) 29
6-minute walk test (28) 28
nitric oxide (28) 28
brain natriuretic peptide (27) 27
child (27) 27
hemodynamics - drug effects (27) 27
scleroderma, systemic - complications (27) 27
bosentan therapy (26) 26
endothelin receptor antagonist (26) 26
infusions, intravenous (26) 26
medicine & public health (26) 26
sildenafil citrate (26) 26
adolescent (25) 25
anticoagulants - therapeutic use (25) 25
connective-tissue disease (25) 25
prostanoids (25) 25
clinical trials (24) 24
dosage and administration (24) 24
quality-of-life (24) 24
retrospective studies (24) 24
trial (24) 24
cardiovascular (23) 23
clinical-practice guidelines (23) 23
continuous venovenous hemofiltration (23) 23
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (457) 457
German (11) 11
French (9) 9
Spanish (6) 6
Russian (5) 5
Japanese (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medicine, ISSN 0025-7974, 07/2008, Volume 87, Issue 4, pp. 220 - 233
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Respiratory Physiology & Neurobiology, ISSN 1569-9048, 2007, Volume 158, Issue 1, pp. 59 - 69
Abstract In seven patients with idiopathic or secondary pulmonary arterial hypertension (PAH), ventilation–perfusion ( V ˙ A / Q ˙ ) relationships were... 
Medical Education | Pulmonary/Respiratory | Epoprostenol | Shunt | Mixed venous oxygenation | [formula omitted] Ratios | Pulmonary arterial hypertension | Inhaled iloprost | Hypoxaemia | Multiple inert-gas elimination technique | over(Q, ̇) Ratios | over(V, ̇) | CARDIAC-OUTPUT | CONTINUOUS DISTRIBUTIONS | PHYSIOLOGY | shunt | mixed venous oxygenation | epoprostenol | INEQUALITY | hypoxaemia | MECHANISMS | EXERCISE | ILOPROST | V-A/Q ratios | THERAPY | RESPIRATORY SYSTEM | DISEASE | NITRIC-OXIDE | multiple inert-gas elimination technique | GAS-EXCHANGE | pulmonary arterial hypertension | inhaled iloprost | Blood Pressure | Injections, Intravenous | Humans | Middle Aged | Hypertension, Pulmonary - diagnostic imaging | Hypertension, Pulmonary - physiopathology | Male | Systole | Vascular Resistance - physiology | Forced Expiratory Volume | Epoprostenol - therapeutic use | Cardiac Catheterization | Exercise Test | Inhalation - physiology | Vascular Resistance - drug effects | Female | Hypertension, Pulmonary - drug therapy | Platelet Aggregation Inhibitors - therapeutic use | Echocardiography | Administration, Oral | Vital Capacity | Quality of Life | Aged | Epoprostenol - administration & dosage | Inhalation - drug effects | Index Medicus | nitric-oxide | disease | Medical and Health Sciences | iloprost | Medicin och hälsovetenskap | therapy | exercise | inequality | cardiac-output | gas-exchange | mechanisms | continuous distributions
Journal Article
American Heart Journal, ISSN 0002-8703, 1997, Volume 134, Issue 1, pp. 44 - 54
Journal Article
Journal Article